DEFA14A: Nxu Inc. Secures $3 Million in Private Placement to Bolster Merger with Verde Bioresins

Nxu Inc. has entered into a Securities Purchase Agreement to raise $3 million through a private placement, involving shares, pre-funded warrants, and new warrants, to support its ongoing merger with Verde Bioresins.

Summary

• Nxu, Inc. has entered into a Securities Purchase Agreement with investors to sell securities in a private placement, raising approximately $3 million.
• The offering includes 6,800,000 shares of Class A Common Stock and pre-funded warrants to purchase 5,200,000 shares.
• Series A warrants to purchase up to 6,000,000 shares and Series B warrants with a share count determined later are also part of the deal.
• The pre-funded warrants are exercisable immediately at $0.0001 per share.
• Series A and B warrants are exercisable upon stockholder approval, with the Series A warrants having an exercise price of $0.50, subject to adjustment.
• The Series A warrants include a reset adjustment based on the lowest daily weighted average price or a floor price of $0.0524.
• The number of shares for Series B warrants will be determined on the Reset Date, based on the aggregate purchase price divided by the reset price.
• The warrants include beneficial ownership limitations to prevent any holder from exceeding 4.99% (or 9.99% at the holder's election) of the company's outstanding common stock.
• The agreement includes provisions for adjustments in case of stock dividends, splits, or fundamental transactions, but excludes the pending merger with Verde Bioresins.
• Maxim Group LLC will receive a cash fee of 7.0% of the gross proceeds and reimbursement for up to $50,000 in expenses as a placement agent.
• The company has also entered into a Registration Rights Agreement, requiring it to register the resale of the purchased shares and warrant shares.
• The Resale Registration Statement must be filed within 30 days and declared effective within 50-70 days, with potential liquidated damages for delays.
• Executive officers and directors have agreed to a 30-day lock-up period on their shares.
• Certain individuals have entered into voting agreements to vote in favor of resolutions approving the terms and exercise of the Series A and B warrants.
• The private placement is exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.

Sentiment

Score: 5

Explanation: The announcement is neutral. While the company secures funding, the terms of the warrants and potential dilution create uncertainty.

Positives

• The private placement provides Nxu, Inc. with $3 million in funding.
• The pre-funded warrants provide immediate capital to the company.
• The Registration Rights Agreement aims to provide liquidity for investors.
• Voting agreements from key personnel support the approval of warrant terms.

Negatives

• The Series A warrants are subject to reset adjustments, which could dilute existing shareholders.
• The number of shares issuable under the Series B warrants is not fixed and will be determined on the Reset Date, creating uncertainty.
• The company may be required to pay liquidated damages if it fails to meet the filing and effectiveness deadlines for the Resale Registration Statement.
• The warrants include beneficial ownership limitations which may restrict the investors ability to exercise the warrants.

Risks

• The company may not obtain the required stockholder approvals for the Series A and B warrants.
• The company may fail to file the Resale Registration Statement or cause it to become effective in a timely manner.
• The reset provisions in the Series A warrants and the determination of shares for Series B warrants could lead to significant dilution.
• The company's stock price could be negatively impacted if the market perceives the private placement as dilutive or unfavorable.
• The company's merger with Verde Bioresins may not close.

Future Outlook

The company intends to file a Resale Registration Statement with the SEC to register the resale of the shares and warrant shares. The company is seeking stockholder approval for the issuance of shares underlying the warrants. The company is working towards completing its merger with Verde Bioresins.

Industry Context

This private placement is a common financing strategy for companies, especially those in growth phases or undergoing significant transactions like mergers. It allows them to raise capital quickly without the complexities and time requirements of a public offering. The use of warrants is also a typical feature, providing investors with potential upside while offering the company flexibility.

Comparison to Industry Standards

• Comparable companies raising capital through similar private placements often include those in the renewable energy or sustainable materials sectors, reflecting Nxu's focus through its merger with Verde Bioresins.
• The terms of the warrants, including exercise prices and reset mechanisms, are structured to attract investors while managing potential dilution, similar to deals seen with companies like Clean Energy Fuels Corp. and Amyris, Inc.
• The 7% placement agent fee is within the typical range for such transactions, aligning with fees charged by firms like Maxim Group LLC in similar deals.
• The timelines for filing and effectiveness of the Resale Registration Statement are also standard, reflecting regulatory expectations and the need for timely liquidity for investors.

Corporate Governance

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares and warrants.
• Investors in the private placement gain potential upside through the warrants.
• The company's employees and customers may benefit from the increased financial stability and growth potential resulting from the funding and merger.

Next Steps

• The company needs to file the Resale Registration Statement with the SEC within 30 days.
• The company needs to obtain stockholder approval for the issuance of shares underlying the Series A and B warrants.
• The company needs to work towards completing its merger with Verde Bioresins.

Key Dates

Keywords

private placement, warrants, registration rights, securities purchase agreement, merger, NXU, Verde Bioresins, common stock, capital raise, dilution